by Stacey Johnson | Apr 13, 2018
For those who aren’t familiar with THIW, there are parties but no films getting their world premieres. The comparison I’m making in the title is to the fact THIW is becoming a must-attend week-long event, with so much going on from morning to night, that serious...
by Stacey Johnson | Mar 30, 2018
Canada’s reputation for excellent science in the field of regenerative medicine can be traced back to the University of Toronto (U of T). Quite literally, Drs. James Till and Ernest McCulloch were U of T researchers when they discovered stem cells in the early 1960s....
by Sowmya Viswanathan | Mar 12, 2018
Dr. Sheng Lin-Gibson is the Chief of Biosystems and Biomaterials Division at the U.S. National Institute of Standards and Technology (NIST) and directs its Regenerative Medicine Programs. She serves as the Convenor of ISO/TC 276: Biotechnology Working Group...
by Stacey Johnson | Feb 2, 2018
Cell and Gene Therapy World, or “Phacilitate” as delegates like to refer to it, happened last week in Miami, Florida (January 22-25). The conference, with 1,500 in attendance, brings together industry professionals from more than 30 countries. The event...
by Sara M. Nolte | Jan 15, 2018
With the start of a new year, I like to take a moment to think about what things in cancer research got me really excited the previous year. Beyond a doubt, that thing for me in 2017 was the first (and second!) FDA approval of a CAR T-cell (chimeric antigen receptor...
by Sowmya Viswanathan | Jan 8, 2018
In this month’s blog on addressing specific bioprocess and bioanalytical challenges to develop Cell and Gene Therapies (CGTs), we hear from Dr. Nick Timmins on quantifying performance of CGTs using cell yield, and some of the methods to measure it, as a metric...
Comments